Acotec Scientific Holdings Limited (6669.HK)

HKD 7.98

(-1.24%)

EBITDA Summary of Acotec Scientific Holdings Limited

  • Acotec Scientific Holdings Limited's latest annual EBITDA in 2023 was 70.54 Million CNY , down -19.9% from previous year.
  • Acotec Scientific Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 21.24 Million CNY , down 0.0% from previous quarter.
  • Acotec Scientific Holdings Limited reported an annual EBITDA of 91.17 Million CNY in 2022, up 267.9% from previous year.
  • Acotec Scientific Holdings Limited reported an annual EBITDA of -51.01 Million CNY in 2021, down -125.84% from previous year.
  • Acotec Scientific Holdings Limited reported a quarterly EBITDA of 21.24 Million CNY for 2024 Q1, up 667.56% from previous quarter.
  • Acotec Scientific Holdings Limited reported a quarterly EBITDA of 14.49 Million CNY for 2023 Q1, up 343.87% from previous quarter.

Annual EBITDA Chart of Acotec Scientific Holdings Limited (2023 - 2019)

Historical Annual EBITDA of Acotec Scientific Holdings Limited (2023 - 2019)

Year EBITDA EBITDA Growth
2023 70.54 Million CNY -19.9%
2022 91.17 Million CNY 267.9%
2021 -51.01 Million CNY -125.84%
2020 -24.66 Million CNY -180.77%
2019 29.86 Million CNY 0.0%

Peer EBITDA Comparison of Acotec Scientific Holdings Limited

Name EBITDA EBITDA Difference
Vincent Medical Holdings Limited 104.43 Million HKD 32.451%